Literature DB >> 25939416

Connective tissue diseases: Is SLE many single-organ diseases or an overlapping spectrum?

Joan T Merrill1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25939416     DOI： 10.1038/nrrheum.2015.61

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  7 in total

1.  Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.

Authors:  Marie B Condon; Damien Ashby; Ruth J Pepper; H Terence Cook; Jeremy B Levy; Megan Griffith; Tom D Cairns; Liz Lightstone
Journal:  Ann Rheum Dis       Date:  2013-06-05       Impact factor: 19.103

2.  Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.

Authors:  Brad H Rovin; Richard Furie; Kevin Latinis; R John Looney; Fernando C Fervenza; Jorge Sanchez-Guerrero; Romeo Maciuca; David Zhang; Jay P Garg; Paul Brunetta; Gerald Appel
Journal:  Arthritis Rheum       Date:  2012-01-09

3.  Treatment Algorithms in Systemic Lupus Erythematosus.

Authors:  Chayawee Muangchan; Ronald F van Vollenhoven; Sasha R Bernatsky; C Douglas Smith; Marie Hudson; Murat Inanç; Naomi F Rothfield; Peter T Nash; Richard A Furie; Jean-Luc Senécal; Vinod Chandran; Ruben Burgos-Vargas; Rosalind Ramsey-Goldman; Janet E Pope
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-09       Impact factor: 4.794

4.  Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.

Authors:  Patricia López; Dagmar Scheel-Toellner; Javier Rodríguez-Carrio; Luis Caminal-Montero; Caroline Gordon; Ana Suárez
Journal:  Rheumatology (Oxford)       Date:  2014-06-18       Impact factor: 7.580

5.  Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.

Authors:  Joan T Merrill; C Michael Neuwelt; Daniel J Wallace; Joseph C Shanahan; Kevin M Latinis; James C Oates; Tammy O Utset; Caroline Gordon; David A Isenberg; Hsin-Ju Hsieh; David Zhang; Paul G Brunetta
Journal:  Arthritis Rheum       Date:  2010-01

6.  Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.

Authors:  Susan Manzi; Jorge Sánchez-Guerrero; Joan T Merrill; Richard Furie; Dafna Gladman; Sandra V Navarra; Ellen M Ginzler; David P D'Cruz; Andrea Doria; Simon Cooper; Z John Zhong; Douglas Hough; William Freimuth; Michelle A Petri
Journal:  Ann Rheum Dis       Date:  2012-05-01       Impact factor: 19.103

7.  Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’ – Authors’ reply.

Authors:  Zana Brkic; Odilia B J Corneth; Marjan A Versnel; Erik Lubberts
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156
  7 in total
  4 in total

Review 1.  Lupus community panel proposals for optimising clinical trials: 2018.

Authors:  Joan T Merrill; Susan Manzi; Cynthia Aranow; Anca Askanase; Ian Bruce; Eliza Chakravarty; Ben Chong; Karen Costenbader; Maria Dall'Era; Ellen Ginzler; Leslie Hanrahan; Ken Kalunian; Joseph Merola; Sandra Raymond; Brad Rovin; Amit Saxena; Victoria P Werth
Journal:  Lupus Sci Med       Date:  2018-03-23

2.  Global consensus building and prioritisation of fundamental lupus challenges: the ALPHA project.

Authors:  Susan Manzi; Sandra Raymond; Karin Tse; Yaritza Peña; Annick Anderson; Kathleen Arntsen; Sang-Cheol Bae; Ian Bruce; Thomas Dörner; Kenneth Getz; Leslie Hanrahan; Amy Kao; Eric Morand; Brad Rovin; Laura Eve Schanberg; Joan M Von Feldt; Victoria P Werth; Karen Costenbader
Journal:  Lupus Sci Med       Date:  2019-07-19

3.  The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research.

Authors:  Karin Tse; Sanjyot Sangodkar; Lauren Bloch; Kathleen Arntsen; Sang-Cheol Bae; Ian N Bruce; Erin Connolly-Strong; Karen H Costenbader; Bradley Dickerson; Thomas Dörner; Sydney Evans; Kenneth Kalunian; Amy H Kao; Susan Manzi; Eric F Morand; Sandra C Raymond; Brad H Rovin; Laura Eve Schanberg; Joan M Von Feldt; Victoria P Werth; Angel Williams Derricott; David Zook; Timothy Franson; Kenneth Getz; Yaritza Peña; Leslie M Hanrahan
Journal:  Lupus Sci Med       Date:  2021-02

4.  Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.